Transamerica Financial Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-3
| Closed | -$1K | – | 650 |
|
2023
Q4 | $1K | Hold |
3
| – | – | ﹤0.01% | 491 |
|
2023
Q3 | $1K | Hold |
3
| – | – | ﹤0.01% | 514 |
|
2023
Q2 | $1K | Buy |
+3
| New | +$1K | ﹤0.01% | 485 |
|
2023
Q1 | – | Sell |
-3
| Closed | -$1K | – | 658 |
|
2022
Q4 | $1K | Hold |
3
| – | – | ﹤0.01% | 532 |
|
2022
Q3 | $1K | Hold |
3
| – | – | ﹤0.01% | 500 |
|
2022
Q2 | $1K | Buy |
+3
| New | +$1K | ﹤0.01% | 512 |
|
2020
Q3 | – | Sell |
-3
| Closed | -$1K | – | 328 |
|
2020
Q2 | $1K | Buy |
+3
| New | +$1K | ﹤0.01% | 411 |
|
2019
Q3 | – | Sell |
-12
| Closed | -$1K | – | 298 |
|
2019
Q2 | $1K | Buy |
+12
| New | +$1K | ﹤0.01% | 464 |
|
2019
Q1 | – | Sell |
-12
| Closed | -$1K | – | 265 |
|
2018
Q4 | $1K | Sell |
12
-3
| -20% | -$250 | ﹤0.01% | 432 |
|
2018
Q3 | $1K | Hold |
15
| – | – | ﹤0.01% | 435 |
|
2018
Q2 | $1K | Sell |
15
-3
| -17% | -$200 | ﹤0.01% | 402 |
|
2018
Q1 | $1K | Sell |
18
-6
| -25% | -$333 | ﹤0.01% | 382 |
|
2017
Q4 | $2K | Hold |
24
| – | – | ﹤0.01% | 312 |
|
2017
Q3 | $2K | Sell |
24
-6,537
| -100% | -$545K | ﹤0.01% | 316 |
|
2017
Q2 | $340K | Buy |
6,561
+453
| +7% | +$23.5K | 0.05% | 197 |
|
2017
Q1 | $308K | Sell |
6,108
-45
| -0.7% | -$2.27K | 0.04% | 203 |
|
2016
Q4 | $290K | Buy |
+6,153
| New | +$290K | 0.03% | 201 |
|
2015
Q3 | – | Sell |
-3
| Closed | -$1K | – | 874 |
|
2015
Q2 | $1K | Hold |
3
| – | – | ﹤0.01% | 818 |
|
2015
Q1 | $1K | Hold |
3
| – | – | ﹤0.01% | 817 |
|
2014
Q4 | $1K | Hold |
3
| – | – | ﹤0.01% | 660 |
|
2014
Q3 | $1K | Hold |
3
| – | – | ﹤0.01% | 621 |
|
2014
Q2 | $1K | Hold |
3
| – | – | ﹤0.01% | 627 |
|
2014
Q1 | $1K | Buy |
+3
| New | +$1K | ﹤0.01% | 592 |
|